Osiris Therapeutics Announces Scientific Manuscript Reporting Antimicrobial Properties of Cryopreserved Viable Amnion is Available ...
COLUMBIA, Md., Jan. 13, 2017 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ:OSIR), announced today that a new peer-reviewed manuscript “Human cryopreserved viable amniotic membrane inhibits the growth of bacteria associated with chronic wounds” ( …